ACIU: AC Immune SA Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 335.42
Enterprise Value ($M) n/a
Book Value ($M) 144.68
Book Value / Share 1.54
Price / Book n/a
NCAV ($M) 87.27
NCAV / Share 0.93
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -0.37
Return on Assets (ROA) -0.32
Return on Equity (ROE) -0.36

Liquidity (mrq)
Quick Ratio 7.78
Current Ratio 7.78

Balance Sheet (mrq) ($M)
Current Assets 109.87
Assets 167.28
Liabilities 22.60
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 14.80
Operating Income -53.62
Net Income -54.23

Cash Flow Statement (mra) ($M)
Cash From Operations -60.41
Cash from Investing 65.64
Cash from Financing 43.25

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-09 13G/A AFFiRiS AG 6.66 -2.18
12-19 13G/A Biotechnology Value Fund L P 14.80 96.16

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-24 117,685 86,055 136.76
2024-05-23 106,589 86,200 123.65
2024-05-22 93,852 47,490 197.62
2024-05-21 131,643 104,172 126.37
2024-05-20 60,142 85,399 70.42

(click for more detail)

Similar Companies
ACAB – Atlantic Coastal Acquisition Corp. II ACET – Adicet Bio, Inc.
ACRV – Acrivon Therapeutics, Inc. ADMA – ADMA Biologics, Inc.


Financial data and stock pages provided by
Fintel.io